Bristol Myers Squibb rallies 40% in a year but trades under 10x earnings
Bristol Myers Squibb stock is up about 40% over the past year, yet BMY changes hands under 10 times forward earnings. Q2's growth-portfolio numbers and the October 29 Q3 report decide whether that discount survives.